The expression and clinical significance of TGF-β1 and MMP2 in Human Renal Clear Cell Carcinoma

International Journal of Surgical Pathology

Volumn 18, Issue 2, 2010, Pages 85-93

  Yang, Shu Dong ^a   Sun, Rong Chao ^a   Mu, Hui Jun ^a   Xu, Zhuo Qun ^a   Zhou, Zhi Yi ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; MMP2; Renal clear cell carcinoma; Reverse transcription polymerase chain reaction; TGF 1

Indexed keywords

GELATINASE A; MOLECULAR MARKER; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CLEAR CELL CARCINOMA; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RENAL CLEAR CELL CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHINA; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77949897076     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896909331993     Document Type: Article

References (22)

1. Zhao W., Kobayashi M., Yuan L., et al. Suppression of in vivo tumorigenicity of rat hepatoma cell line KDH-8 cells by soluble TGF-beta receptor type II. Cancer Immunol Immunother. 2002 ; 51: 381-388.
2. Huntley SP, Davies M., Matthews JB, et al. Attenuated type II TGF-beta receptor signaling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination. Int J Cancer. 2004 ; 110: 170-176.
3. Yamamura T., Nakanishi K., Hiroi S., et al. Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in nonsmall cell lung carcinomas. Lung Cancer. 2002 ; 35: 249-255.
4. Sela BA Matrix metalloproteinase: promoters of tumor progression and invasiveness. Isr Med Assoc J. 2002 ; 4: 280-282.
5. Ibrahim EC, Allory Y., Commo F., Gattegno B., Callard P., Paul P. Altered pattern of major histocompatibility complex expression in renal carcinoma: Tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma. Am J Pathol. 2003 ; 162: 501-508.
6. Miyazono K. TGF-beta/SMAD signaling and its involvement in tumor progression. Biol Pharm Bull. 2000 ; 23: 1125-1130.
7. Pasche B. Role of TGF-β in cancer. J Cell Physiol. 2001 ; 186: 153-168.
8. Tjiong MY, van der Vange N., ter Schegget JS, Burger MP, ten Kate FW, Out TA Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine. 2001 ; 14: 357-360.
9. Lang F., Klingel K., Wagner CA, et al. Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci USA. 2000 ; 97: 8157-8162.
10. Julie AM, James JK, Vivian M., et al. Invasion and metastasis of a mammary tumor involves TGF-β signaling. Int J Cancer. 2001 ; 91: 76-82.
11. Kirimca F., Sariolu S., Kamsari C., Kavuku S. Expression of CD44 and major histocompatibility complex II antigens correlate with renal scarring in primary and systemic renal diseases. Scand J Urol Nephrol. 2001 ; 35: 509-514.
12. Edwards JG, McLaren J., Jones JL, Waller DA, OByrne KJ Matrix metalloproteinases2 and 9(gelatinases A and B) expression in malignant mesothelioma and benign pleura. Br J Cancer. 2003 ; 88: 1553-1559.
13. Mook OR, Frederiks WM, Van Noorden CJ The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta. 2004 ; 1705: 69-89.
14. Patel BP, Shah PM, Rawal UM, et al. Activation of MMP-2 and MMP-9 in patients witll oral squamous cell carcinoma. J Surg Oncol. 2005 ; 90: 81-88.
15. Fukata S., Inoue K., Kamada M., et al. Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ specific metastasis of renal cell carcinoma. Cancer. 2005 ; 103: 931-942.
16. Malhotra S., Newman E., Eisenberg D., et al. Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer: a possible mechanism of neoplastic progression. Dis Colon Rectum. 2002 ; 45: 537-543.
17. Di Nezza LA, Misajon A., Zhang J., et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer. 2002 ; 94: 1466-1475.
18. Huang X., Lee C. From TGF-beta to cancer therapy. Curr Drug Targets. 2003 ; 4: 243-250.
19. Logullo AF, Nonogaki S., Miguel RE, et al. Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis. J Oral Pathol Med. 2003 ; 32: 139-145.
20. Fang J., Shing Y., Wiederschain D., et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA. 2000 ; 97: 3884-3889.
21. Ivaska J., Heino J. Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix. Cell Mol Life Sci. 2000 ; 57: 16-24.
22. Deryugina EI, Bourdon MA, Jungwirth K., Smith JW, Strongin AY Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer. 2000 ; 86: 15-23.